Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 545 of 6351
-
New drug combo aims to fight deadly gallbladder cancer
Disease control Recruiting nowThis is a randomized, open-label, phase II study evaluating first-line treatment for advanced gallbladder cancer. It aims to assess the efficacy, safety, pharmacokinetics, and immunogenicity of the ZG005 in Combination with gemcitabine and cisplatin as first-line therapy in Parti…
Phase 2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug combo aims to wipe out hidden myeloma cells
Disease control Recruiting nowThe purpose of this study is to determine whether giving linvoseltamab with lenalidomide during maintenance treatment to participants with multiple myeloma will: 1. Get rid of any residual multiple myeloma cells in participants' bodies which is known as minimal residual disease …
Phase 2 • Sponsor: Dickran Kazandjian, MD • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
5-Day therapy aims to ease PTSD, insomnia, and nightmares for veterans
Symptom relief Recruiting nowThis study is a two-arm individually randomized group treatment clinical trial evaluating behavioral therapies for insomnia, nightmares, and PTSD. The study will compare cognitive-behavioral therapy for insomnia and nightmares to sleep hygiene (Control), both integrated with Writ…
Sponsor: Palo Alto Veterans Institute for Research • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New scan could spot pancreatic cancer relapse months earlier
Diagnosis Recruiting nowAssessment of the relevance of a new medical imaging test, FAPI PET, which could detect progression or relapse earlier than other tests currently available. Ultimately, it could enable early forms of pancreatic cancer to be detected and used for screening. In addition to the usu…
Phase 2 • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
New drug aims to shield heart and kidneys from major events
Disease control Recruiting nowThe purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Poop pills take on superbugs in new clinical trial
Disease control Not yet recruitingThe aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.
Sponsor: Kyungpook National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New cocktail of chemo, immunotherapy, and bladder drug takes on recurrent ovarian cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn if drug regimen weekly paclitaxel/nab-paclitaxel, pembrolizumab, and mirabegron works to treat relapsed ovarian cancer in adults. It will also learn about the safety of the drug regimen. The main questions it aims to answer are: i) Doe…
Phase 2 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New mRNA vaccine targets brain tumors in early trial
Disease control Recruiting nowThis clinical trial is designed to evaluate the safety and efficacy of a universal mRNA vaccine targeting a panel of glioma-associated mutations in patients with recurrent or progressive high-grade glioma. The primary objectives are to address the following key questions: 1) Is …
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New targeted drug combo aims to shrink breast tumors before surgery
Disease control Not yet recruitingThis is a prospective, randomized, multi-cohort, Phase II clinical trial. The study plans to enroll 120 patients with early-stage or locally advanced, HR-positive, HER2-low breast cancer. The primary objective is to evaluate the efficacy and safety of SHR-A1811 with or without en…
Phase 2 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug duo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis is a prospective, single-arm, multi-center Phase II clinical trial designed to evaluate the efficacy and safety of neoadjuvant therapy with SHR-A1811 in combination with Adebelimumab in patients with resectable, early-stage non-small cell lung cancer (NSCLC) harboring HER2 a…
Phase 2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental immune cell combo targets Drug-Resistant lung cancer
Disease control Recruiting nowThis prospective Phase II study aims to evaluate the preliminary efficacy and safety of WAST cells combined with docetaxel as second-line therapy in patients with advanced NSCLC resistant to PD-1 inhibitors.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Triple threat: radiation, chemo, and immunotherapy join forces against advanced rectal cancer
Disease control Recruiting nowTo enhance the treatment efficacy of rectal cancer liver metastasis through a multidisciplinary approach of radiotherapy, immunotherapy, and chemotherapy, and to provide a new direction for the combination treatment strategy.
Phase 2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Immune army targets ovarian cancer in new trial
Disease control By invitation onlyThis is a single-arm, open-label, phase I/II trial to evaluate the safety and efficacy of ovarian cancer-specific, engineered immune effectors (OC-EIEs) in women.
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a smart device at home tame Post-Surgery pain and prevent chronic pain?
Disease control Recruiting nowAcute postoperative pain (APOP) is a major public health problem, affecting nearly 10 million patients in France each year. Effective analgesic therapy in the first postoperative week is a key factor in reducing early postoperative morbidity and mortality. Poorly controlled APOP …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a classroom program heal trauma in teens?
Symptom relief Recruiting nowThis study will evaluate whether a school-based counseling program, Cognitive Behavioral Intervention for Trauma in Schools (CBITS), helps reduce trauma-related symptoms and improve psychological functioning in adolescents in Pakistan who have experienced traumatic events. Studen…
Sponsor: National University of Modern Languages • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo aims to keep bladder cancer from coming back
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine (Disitamab Vedotin) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder,…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a short class tilt the odds toward vaginal birth?
Prevention CompletedConsidering the increasing rates of cesarean delivery in Turkey, we aimed to research the impact of antenatal education on pregnancy, the childbirth process, the cesarean section rate, and the postpartum period through a randomized controlled study. METHOD: A total of 120 pregnan…
Sponsor: Saglik Bilimleri Universitesi • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
New cell therapy aims to make mismatched donor transplants safer for blood cancer patients
Disease control Recruiting nowThe study goal is to characterize the safety of the combination of Orca-T with dual agent GVHD prophylaxis.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New surgery aims to stop lymphedema before it starts
Prevention Recruiting nowImmediate lymphatic reconstruction (ILR) is a novel surgical approach performed at the time of initial lymph node dissection with the goal of preventing lymphedema.(Chang et al. 2020) It involves the identification of lymphatic channels that are transected after lymph node dissec…
Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
New hope for liver cancer: pfizer tests experimental drug
Disease control Recruiting nowThe purpose of this study is to learn about the effects of study medicine (PF-08634404) when given alone or with another antibody (ipilimumab) for the treatment of a type of liver cancer called hepatocellular carcinoma (HCC) that is either locally advanced (spread to nearby tissu…
Phase 1/2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC